Related Experiment Video
Updated: Jun 3, 2026
11:11
Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts
Published on: December 17, 2016
Current advances in retroviral gene therapy
Youngsuk Yi1, Moon Jong Noh, Kwan Hee Lee
1TissueGene, Inc., Rockville, MD 20850, USA.
Current Gene Therapy
|April 2, 2011
Summary
Gene therapy using lentiviral vectors shows safety concerns, as seen in a beta-thalassemia trial. Further improvements in vector safety are needed to prevent oncogenesis and ensure effective gene delivery.
Area of Science:
- Gene therapy
- Hematopoietic stem cell transplantation
- Oncogenesis
Background:
- Retroviral gene therapy for X-SCID led to leukemia due to oncogenesis.
- Lentiviral vectors were developed to improve safety but still show risks.
- A recent clinical trial revealed clonal dominance in a beta-thalassemia patient post-lentiviral therapy.
Purpose of the Study:
- To review safety features implemented in retroviral gene therapy.
- To discuss potential improvements for lentiviral vector safety.
- To address oncogenesis risks associated with gene therapy vectors.
Main Methods:
- Review of existing safety strategies for retroviral gene therapy.
- Discussion of novel approaches to enhance lentiviral vector safety.
- Analysis of clinical trial outcomes regarding vector-induced clonal effects.
Main Results:
- Previous retroviral gene therapy caused leukemia due to insertional activation.
- Lentiviral vectors, while advanced, demonstrated insufficient safety in a recent trial.
- Clonal dominance was observed in a beta-thalassemia patient treated with lentiviral vectors.
Conclusions:
- Current lentiviral vector systems require significant safety enhancements.
- Strategies like chromatin insulators and inducible suicide genes may improve safety.
- Further research is crucial for developing safer gene therapy vectors.
More Related Videos
12:53Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow
Published on: June 14, 2017
07:43A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears
Published on: July 14, 2023
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...